ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PMN ProMIS Neurosciences Inc

盘后交易 02-13 16:03:42 EST

15.25

+0.29

+1.94%

盘后15.25

+0.000.00%

16:00 EST

最高15.35	最低14.99	成交量1.71万
今开15.29	昨收14.96	日振幅2.41%
总市值3,282万	流通市值1,555万	总股本215.24万
成交额26.05万	换手率1.68%	流通股本101.99万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":15.25,"timestamp":1771016400000,"preClose":14.96,"halted":0,"volume":17138,"hourTrading":{"tag":"盘后","latestPrice":15.25,"preClose":15.25,"latestTime":"16:00 EST","volume":205,"amount":3126.25,"timestamp":1771016401065,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.019385026737967857,"floatShares":1019940,"shares":2152444,"eps":-20.049492,"marketStatus":"盘后交易","change":0.29,"latestTime":"02-13 16:03:42 EST","open":15.29,"high":15.35,"low":14.99,"amount":260505.723412,"amplitude":0.024064,"askPrice":16.6,"askSize":5,"bidPrice":14.57,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-20.049492,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771030800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":14.96,"preHourTrading":{"tag":"盘前","latestPrice":14.9476,"preClose":14.96,"latestTime":"09:25 EST","volume":92,"amount":1363.076048,"timestamp":1770992705486,"change":-0.0124,"changeRate":-0.000829,"amplitude":0.009866},"postHourTrading":{"tag":"盘后","latestPrice":15.25,"preClose":15.25,"latestTime":"16:00 EST","volume":205,"amount":3126.25,"timestamp":1771016401065,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.420403},"requestUrl":"/m/hq/s/PMN/tweets","defaultTab":"tweets","newsList":[{"id":"1163920950","title":"ProMIS Neurosciences：募资所得预计将助力完成具有里程碑意义的1b期阿尔茨海默病研究，并支持关键临床里程碑的推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1163920950","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163920950?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:05","pubTimestamp":1769778312,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc (PMN) 近日宣布，其通过融资所获得的资金预计将为公司完成其具有里程碑意义的1b期阿尔茨海默病（AD）研究提供关键支持。这笔资金还将用于推动公司实现其他重要的临床开发里程碑，为公司后续的临床进展和管线发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"2607264724","title":"Promis Neurosciences Inc.盘中异动 急速拉升7.22%报11.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607264724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607264724?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:28","pubTimestamp":1769621309,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日01时28分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨7.22%。截至发稿，该股报11.43美元/股，成交量7344股，换手率0.34%，振幅3.66%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129012829a6b834dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129012829a6b834dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","PMN","BK4139"],"gpt_icon":0},{"id":"2603245485","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603245485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603245485?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:38","pubTimestamp":1768228716,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时38分，Promis Neurosciences Inc.股票出现异动，股价快速上涨7.62%。截至发稿，该股报8.75美元/股，成交量2600股，换手率0.12%，振幅3.81%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223837953c6d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223837953c6d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"gpt_icon":0},{"id":"2595795531","title":"Promis Neurosciences Inc.盘中异动 大幅跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595795531?lang=zh_cn&edition=full","pubTime":"2025-12-29 23:10","pubTimestamp":1767021029,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日23时10分，Promis Neurosciences Inc.股票出现波动，股价急速跳水5.35%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229231030a48699c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229231030a48699c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXD","ARFXF"],"gpt_icon":0},{"id":"2594400189","title":"Promis Neurosciences Inc.盘中异动 临近午盘股价大涨5.97%报8.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594400189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594400189?lang=zh_cn&edition=full","pubTime":"2025-12-25 00:42","pubTimestamp":1766594558,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日00时42分，Promis Neurosciences Inc.股票出现异动，股价快速上涨5.97%。截至发稿，该股报8.62美元/股，成交量5997股，换手率0.28%，振幅3.32%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225004239a4741aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225004239a4741aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","BK4139","ARFXF"],"gpt_icon":0},{"id":"2592145298","title":"Promis Neurosciences Inc.盘中异动 早盘大幅拉升7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592145298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592145298?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:44","pubTimestamp":1766155471,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日22时44分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨7.10%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219224431953b7573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219224431953b7573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","ARFXF","BK4139"],"gpt_icon":0},{"id":"1113080391","title":"ProMIS Neurosciences Inc超越预期招募目标，进行Pmn310的精准老年痴呆症阶段1B临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1113080391","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113080391?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:30","pubTimestamp":1766061014,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc超越预期招募目标，进行Pmn310的精准老年痴呆症阶段1B临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"1135888661","title":"ProMIS Neurosciences发布新的同行评审论文，显示血浆Ptau作为阿尔茨海默症试验中的早期预测终点，支持其正在进行的Phase 1B Precise-Ad试验与Pmn310","url":"https://stock-news.laohu8.com/highlight/detail?id=1135888661","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135888661?lang=zh_cn&edition=full","pubTime":"2025-12-01 20:32","pubTimestamp":1764592352,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences发布新的同行评审论文，显示血浆Ptau作为阿尔茨海默症试验中的早期预测终点，支持其正在进行的Phase 1B Precise-Ad试验与Pmn310。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMN","BK4139"],"gpt_icon":0},{"id":"2580690245","title":"Promis Neurosciences Inc.盘中异动 急速跳水5.44%报0.393美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580690245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580690245?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:17","pubTimestamp":1762186659,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时17分，Promis Neurosciences Inc.股票出现波动，股价急速下挫5.44%。截至发稿，该股报0.393美元/股，成交量23.9505万股，换手率0.45%，振幅5.85%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为1.78%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发抗体疗法，选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症  和多系统萎缩  等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400173994ec81c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400173994ec81c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","PMN","ARFXD"],"gpt_icon":0},{"id":"1164976537","title":"ProMIS Neurosciences 增强董事会，任命 Slanix Paul Alex 博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1164976537","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164976537?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:31","pubTimestamp":1761132676,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences 增强董事会，任命 Slanix Paul Alex 博士为董事会成员，他是 Ally Bridge Group 的公共股权总裁及投资组合经理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"1108610835","title":"ProMIS Neurosciences Inc：试验预计招募128名患者，按计划将在2026年第二季度公布6个月中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1108610835","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108610835?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:07","pubTimestamp":1756897670,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences Inc宣布，其临床试验预计将招募128名患者，目前仍按计划在2026年第二季度报告6个月的中期数据结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PMN"],"gpt_icon":0},{"id":"1179674254","title":"ProMIS Neurosciences获得DSMB批准，其PMN310阿尔茨海默病1B期试验进入最终剂量递增队列","url":"https://stock-news.laohu8.com/highlight/detail?id=1179674254","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179674254?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:01","pubTimestamp":1756897278,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences获得数据安全监查委员会（DSMB）批准，其PMN310阿尔茨海默病1B期临床试验将推进至最终剂量递增队列阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMN","BK4139"],"gpt_icon":0},{"id":"2517574941","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨6.55%报0.830美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517574941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517574941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:57","pubTimestamp":1741190237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时57分，Promis Neurosciences Inc.股票出现波动，股价大幅上涨6.55%。截至发稿，该股报0.830美元/股，成交量7251股，换手率0.02%，振幅3.90%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235717963af135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","ARFXF","PMN"],"gpt_icon":0},{"id":"2516598456","title":"Promis Neurosciences Inc.盘中异动 快速跳水12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516598456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516598456?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:25","pubTimestamp":1741022716,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时25分，Promis Neurosciences Inc.股票出现异动，股价急速下跌12.56%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4182.16%、177.33%、156.20%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304012516abe667ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2514238270","title":"Promis Neurosciences Inc.盘中异动 早盘股价大跌6.49%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514238270?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:04","pubTimestamp":1740672240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时04分，Promis Neurosciences Inc.股票出现波动，股价急速下跌6.49%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000401abdf857d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","ARFXF","PMN"],"gpt_icon":0},{"id":"2512847534","title":"Promis Neurosciences Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512847534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512847534?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:36","pubTimestamp":1739983009,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时36分，Promis Neurosciences Inc.股票出现异动，股价急速下跌5.41%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003649a24c12fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"gpt_icon":0},{"id":"2511452508","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨9.63%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511452508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511452508?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Promis Neurosciences Inc.股票出现异动，股价大幅拉升9.63%。截至发稿，该股报1.000美元/股，成交量2363股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223103abcdb1d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","BK4139","PMN"],"gpt_icon":0},{"id":"2509220600","title":"Promis Neurosciences Inc.盘中异动 大幅上涨5.91%报0.985美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509220600?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:37","pubTimestamp":1738859853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时37分，Promis Neurosciences Inc.股票出现异动，股价急速上涨5.91%。截至发稿，该股报0.985美元/股，成交量6992股，换手率0.02%，振幅3.23%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003733987ca217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","ARFXF","BK4139"],"gpt_icon":0},{"id":"2507624281","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨5.12%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507624281?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:49","pubTimestamp":1738248549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时49分，Promis Neurosciences Inc.股票出现波动，股价急速拉升5.12%。截至发稿，该股报0.940美元/股，成交量2028股，换手率0.01%，振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Promis Neurosciences Inc.公司简介：ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司，专注于生产和开发选择性针对阿尔茨海默病、肌萎缩侧索硬化症和多系统萎缩症等神经退行性疾病毒性错误折叠蛋白的抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302249099876b3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":0.142},{"period":"1month","weight":0.8333},{"period":"3month","weight":0.5359},{"period":"6month","weight":-0.0301},{"period":"1year","weight":-0.344},{"period":"ytd","weight":1.1919}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立，位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台，在神经退行性疾病和其他错误折叠的蛋白质疾病（包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症）中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病，包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质，否则会发挥正常功能，变得有毒并杀死神经元，从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.492325},{"month":2,"riseRate":0.5,"avgChangeRate":-0.032354},{"month":3,"riseRate":0,"avgChangeRate":-0.061506},{"month":4,"riseRate":0.666667,"avgChangeRate":0.13153},{"month":5,"riseRate":0,"avgChangeRate":-0.176878},{"month":6,"riseRate":0,"avgChangeRate":-0.154013},{"month":7,"riseRate":0.333333,"avgChangeRate":0.096733},{"month":8,"riseRate":0,"avgChangeRate":-0.185569},{"month":9,"riseRate":0.5,"avgChangeRate":-0.048217},{"month":10,"riseRate":0.25,"avgChangeRate":-0.042317},{"month":11,"riseRate":0,"avgChangeRate":-0.242658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.058437}],"exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}